Live from TTLC25: Lung Cancer and Brain Metastasis by IASLC

Host: Ece Cali Daylan, Assistant Professor of Medicine, Division of Oncology at Washington University School of Medicine

Guest: Saadettin Kilickap

Guest: Ozden Altundag

As part of IASLC's ongoing series of podcasts in world languages, Dr. Balazs Halmos moderates a discussion in Hungarian with Dr. Krisztina Bogos, Dr. Ferenc Rényi-Vámos and Dr. Zsolt Megyesfalvi. The podcast reviews recent advances in lung cancer screening, diagnosis and management with a particular focus on implementation in Hungary. Highlights of the discussion include novel staging and diagnostic tools, state-of-the-art biomarker testing, perioperative therapy and clinical trials access.

Host: Balazs Halmos, MD, Director, Thoracic Oncology & Clinical Cancer Genomics, Montefiore Medical Park at Eastchester, Bronx, New York

Guest: Ferenc Rényi-Vámos, MD, PhD, Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary

Guest: Krisztina Bogos, MD, Thoracic Oncology National Koranyi Institute of Pulmonology, Budapest, Hungary Lung Cancer Research and Pathology

Guest: Zsolt Megyesfalvi, MD, PhD, Semmelweis University and National Institute of Oncology, Budapest, Hungary and National Koranyi Institute of Pulmonology, Budapest, Hungary

The 2024 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary.

To reach a global audience, IASLC has recorded podcast episodes on WCLC 2024 in world languages.

In this episode, host Dr. Sally Lau moderates a discussion in Cantonese Chinese about highlights from the conference with Dr. David Lee and Dr. Molly Li.

Virtual Tumor Board: Stage III ALK+ NSCLC by IASLC

Live from TTLC25: Targeted Therapy in Early Stage NSCLC Debate by IASLC

In this episode of Lung Cancer Considered, host Dr. Narjust Florez engages in a discussion with patient advocate Summer Farmen. Listen to the episode to learn about Summer’s journey through diagnosis and treatment, and the importance of patient advocate groups.

• Summer Farmen

ALKtALK Program Coordinator

Board Member, ALK Positive, Inc.

In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion of two of the most challenging thoracic malignancies – NUT carcinoma and mesothelioma. Listen to the episode to learn about the role of next-generation sequencing in diagnosis and treatment selection, as well as current and future targeted therapy in the management of both.

Guests

Melina Marmarelis, MD MSCE

Assistant Professor

Medical Director, UPenn Mesothelioma

University of Pennsylvania

Jia Luo, MD

Medical Oncologist, Thoracic Oncology Program, Dana-Farber Cancer Institute

Faculty, Brigham and Women's Hospital and Harvard Medical School

In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion on how small cell lung cancer continues to evolve with new treatment options and recent FDA approval. Listen to the episode to learn about the current standard of care and future therapies with a brief discussion about small cell transformation.

Guest: Triparna Sen, MD

Associate Professor

Director, Lung Cancer PDX Program,

Icahn School of Medicine at Mount Sinai

Guest:

Jacob Sands, MD

Assistant Professor of Medicine, Harvard Medical School

Lowe Cancer Center for Thoracic Oncology

Dana Farber Cancer Institute

Descriptions: As part of the IASLC's ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Bashir Abu Aqeel and Dr. Fawzi Abu Rous. The group discusses chemoimmunotherapy in metastatic non-small cell lung cancer.